|
|
Article: The Zitter Group Deploys Spotfire DecisionSite to Provide Strategic Sales & Marketing Insights to Pharmaceutical Companies; The Zitter Group integrates DecisionSite into Acumen Rx to assess product performance to create new advantages.
- Article from:
- Business Wire
- Article date:
- January 4, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SOMERVILLE, Mass. -- Spotfire, Inc., the leading provider of business analytics software, today announced that The Zitter Group has licensed DecisionSite to enhance the analytical capabilities of its Acumen Rx product. Acumen Rx is a managed care analysis tool that generates powerful insights on a product's payer access and sales performance at the local territory level.
For pharmaceutical companies, competitive advantage can shift daily. There are threats everywhere, from new product entries and innovative marketing strategies to changes in formulary design. With the information advantage provided through the integration of DecisionSite and Acumen Rx, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Calendar
Pharmaceutical Executive;
July 1, 2005 ;
700+ words
... ... Specialty Pharmaceutical Management, Chicago, Illinois. The Zitter Group's meeting aims to bring pharma manufacturers together with ... managers, retail pharmacies, CMS, and FDA. CONTACT The Zitter Group [888] 4-ZITTER, http://www.zitter.com 20-21 ...
|
|